SCHEMBL29583448

SCHEMBL29583448

CC(C)(C)OC(=O)N1CC=C(c2ccc3c4c(cccc24)NC3=O)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK4 Q16654 1/20 0.57
HTR6 P50406 1/20 0.50
CNR1 P21554 1/20 0.48
DGAT2 Q96PD7 1/20 0.46
JAK1 P23458 1/20 0.45
GRM1 Q13255 9/20 0.45
GRM5 P41594 8/20 0.45
NAMPT P43490 1/20 0.44
CCNT1 O60563 1/20 0.42
CDK9 P50750 1/20 0.42
PARP1 P09874 1/20 0.42
TNKS2 Q9H2K2 1/20 0.42
PARP2 Q9UGN5 1/20 0.42
GABRP O00591 1/20 0.41
GABRD O14764 1/20 0.41
GABRA1 P14867 1/20 0.41
GABRB1 P18505 1/20 0.41
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41
GABRA5 P31644 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24330068 1.00 PDK4 (0.57) PDK4HTR6CNR1DGAT2JAK1
SCHEMBL22532889 0.97 PDK4 (0.58) PDK4HTR6CNR1DGAT2JAK1
SCHEMBL30026536 0.97 PDK4 (0.58) PDK4HTR6CNR1DGAT2JAK1
SCHEMBL24315967 0.82 PDK4 (0.50) PDK4HTR6CNR1JAK1GRM1
SCHEMBL22532732 0.81 KDM4E (0.45) PDK4
SCHEMBL19297151 0.80 PDK4 (0.61) PDK4HTR6CNR1DGAT2JAK1
SCHEMBL30074119 0.80 PDK4 (0.61) PDK4HTR6CNR1JAK1GRM1
SCHEMBL6847847 0.79 PDK4 (0.69) PDK4HTR6CNR1DGAT2JAK1
SCHEMBL19297042 0.79 PDK4 (0.62) PDK4HTR6CNR1DGAT2JAK1
SCHEMBL19284578 0.79 PDK4 (0.65) PDK4HTR6CNR1DGAT2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4228625-A1 TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED PROTEINS C4 Therapeutics, Inc. (US) 2023-08-23 EP disclosed
WO-2022081928-A1 TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED PROTEINS C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed